CGM Stock Overview
Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide.
Price History & Performance
|Historical stock prices|
|Current Share Price||€24.50|
|52 Week High||€29.80|
|52 Week Low||€20.00|
|1 Month Change||-0.41%|
|3 Month Change||16.39%|
|1 Year Change||1.03%|
|3 Year Change||-5.41%|
|5 Year Change||-18.98%|
|Change since IPO||142.86%|
Recent News & Updates
Is Now The Time To Put Cegedim (EPA:CGM) On Your Watchlist?
For beginners, it can seem like a good idea (and an exciting prospect) to buy a company that tells a good story to...
|CGM||FR Healthcare Services||FR Market|
Return vs Industry: CGM exceeded the French Healthcare Services industry which returned -21.4% over the past year.
Return vs Market: CGM exceeded the French Market which returned -5.9% over the past year.
|CGM Average Weekly Movement||7.4%|
|Healthcare Services Industry Average Movement||7.5%|
|Market Average Movement||5.9%|
|10% most volatile stocks in FR Market||10.0%|
|10% least volatile stocks in FR Market||3.4%|
Stable Share Price: CGM is not significantly more volatile than the rest of French stocks over the past 3 months, typically moving +/- 7% a week.
Volatility Over Time: CGM's weekly volatility (7%) has been stable over the past year.
About the Company
Cegedim SA operates as a technology and services company in the digital data flow management for healthcare ecosystem and B2B, and business software publisher for healthcare and insurance professionals worldwide. It operates in two divisions, Health Insurance, HR and e-Services; and Healthcare Professionals. The Health Insurance, HR and e-Services division markets various products and services to insurance companies, mutual insurers, personal protection insurers, and insurance brokers, as well as engages in the interactions between these entities and healthcare professionals.
Cegedim Fundamentals Summary
|CGM fundamental statistics|
Is CGM overvalued?See Fair Value and valuation analysis
Earnings & Revenue
|CGM income statement (TTM)|
|Cost of Revenue||€305.98m|
Last Reported Earnings
Dec 31, 2021
Next Earnings Date
Sep 20, 2022
|Earnings per share (EPS)||1.91|
|Net Profit Margin||5.00%|
How did CGM perform over the long term?See historical performance and comparison
2.0%Current Dividend Yield
Does CGM pay a reliable dividends?See CGM dividend history and benchmarks
|Cegedim dividend dates|
|Ex Dividend Date||Jun 29 2022|
|Dividend Pay Date||Jul 01 2022|
|Days until Ex dividend||31 days|
|Days until Dividend pay date||33 days|
Does CGM pay a reliable dividends?See CGM dividend history and benchmarks
Is Cegedim undervalued compared to its fair value and its price relative to the market?
Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
PE vs Industry
PE vs Market
PB vs Industry
Undervalued compared to fair value
Share Price vs. Fair Value
Below Fair Value: CGM (€24.5) is trading below our estimate of fair value (€59.88)
Significantly Below Fair Value: CGM is trading below fair value by more than 20%.
Price To Earnings Ratio
PE vs Industry: CGM is good value based on its Price-To-Earnings Ratio (12.8x) compared to the European Healthcare Services industry average (34.8x).
PE vs Market: CGM is good value based on its Price-To-Earnings Ratio (12.8x) compared to the French market (16.2x).
Price to Earnings Growth Ratio
PEG Ratio: CGM is poor value based on its PEG Ratio (2.2x)
Price to Book Ratio
PB vs Industry: CGM is good value based on its Price-To-Book Ratio (1.4x) compared to the FR Healthcare Services industry average (2.7x).
How is Cegedim forecast to perform in the next 1 to 3 years based on estimates from 4 analysts?
Future Growth Score1/6
Future Growth Score 1/6
Earnings vs Savings Rate
Earnings vs Market
High Growth Earnings
Revenue vs Market
High Growth Revenue
Forecasted annual earnings growth
Earnings and Revenue Growth Forecasts
Analyst Future Growth Forecasts
Earnings vs Savings Rate: CGM's forecast earnings growth (5.7% per year) is above the savings rate (0.3%).
Earnings vs Market: CGM's earnings (5.7% per year) are forecast to grow slower than the French market (11.9% per year).
High Growth Earnings: CGM's earnings are forecast to grow, but not significantly.
Revenue vs Market: CGM's revenue (4% per year) is forecast to grow slower than the French market (5.8% per year).
High Growth Revenue: CGM's revenue (4% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: CGM's Return on Equity is forecast to be low in 3 years time (10.7%).
How has Cegedim performed over the past 5 years?
Past Performance Score5/6
Past Performance Score 5/6
Growing Profit Margin
Earnings vs Industry
Historical annual earnings growth
Earnings and Revenue History
Quality Earnings: CGM has high quality earnings.
Growing Profit Margin: CGM's current net profit margins (5%) are higher than last year (2.2%).
Past Earnings Growth Analysis
Earnings Trend: CGM has become profitable over the past 5 years, growing earnings by 61.7% per year.
Accelerating Growth: CGM's earnings growth over the past year (142%) exceeds its 5-year average (61.7% per year).
Earnings vs Industry: CGM earnings growth over the past year (142%) exceeded the Healthcare Services industry -3%.
Return on Equity
High ROE: CGM's Return on Equity (11.3%) is considered low.
How is Cegedim's financial position?
Financial Health Score3/6
Financial Health Score 3/6
Short Term Liabilities
Long Term Liabilities
Financial Position Analysis
Short Term Liabilities: CGM's short term assets (€232.7M) do not cover its short term liabilities (€263.7M).
Long Term Liabilities: CGM's short term assets (€232.7M) do not cover its long term liabilities (€301.5M).
Debt to Equity History and Analysis
Debt Level: CGM's net debt to equity ratio (71%) is considered high.
Reducing Debt: CGM's debt to equity ratio has reduced from 132.2% to 81.4% over the past 5 years.
Debt Coverage: CGM's debt is well covered by operating cash flow (50.7%).
Interest Coverage: CGM's interest payments on its debt are well covered by EBIT (4.8x coverage).
What is Cegedim current dividend yield, its reliability and sustainability?
Dividend Score 3/6
Future Dividend Coverage
Current Dividend Yield
Upcoming Dividend Payment
Dividend Yield vs Market
Notable Dividend: CGM's dividend (2.04%) is higher than the bottom 25% of dividend payers in the French market (1.72%).
High Dividend: CGM's dividend (2.04%) is low compared to the top 25% of dividend payers in the French market (5.01%).
Stability and Growth of Payments
Stable Dividend: Too early to tell whether CGM's dividend payments have been stable as they only just started paying a dividend.
Growing Dividend: Too early to tell if CGM's dividend payments are increasing as they only just started paying a dividend.
Earnings Payout to Shareholders
Earnings Coverage: With its reasonably low payout ratio (26.3%), CGM's dividend payments are well covered by earnings.
Cash Payout to Shareholders
Cash Flow Coverage: With its low cash payout ratio (21.9%), CGM's dividend payments are well covered by cash flows.
Discover strong dividend paying companies
How experienced are the management team and are they aligned to shareholders interests?
Average management tenure
Mr. Jean-Claude Labrune has been the Chief Executive Officer of Cegedim SA since August 18, 1994. Mr. Labrune serves as President of S.A.S. He founded Cegedim SA in 1969 and served as its Managing Director...
CEO Compensation Analysis
Compensation vs Market: Jean-Claude's total compensation ($USD293.55K) is below average for companies of similar size in the French market ($USD479.65K).
Compensation vs Earnings: Jean-Claude's compensation has been consistent with company performance over the past year.
Experienced Management: CGM's management team is seasoned and experienced (16.2 years average tenure).
Experienced Board: CGM's board of directors are considered experienced (5.9 years average tenure).
Who are the major shareholders and have insiders been buying or selling?
Insider Trading Volume
Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.
Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.
Cegedim SA's employee growth, exchange listings and data sources
- Name: Cegedim SA
- Ticker: CGM
- Exchange: ENXTPA
- Founded: 1969
- Industry: Health Care Technology
- Sector: Healthcare
- Implied Market Cap: €335.709m
- Shares outstanding: 13.70m
- Website: https://www.cegedim.com
Number of Employees
- Cegedim SA
- 137 rue d'Aguesseau
Company Analysis and Financial Data Status
|Data||Last Updated (UTC time)|
|Company Analysis||2022/05/27 00:00|
|End of Day Share Price||2022/05/27 00:00|
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.